Skip to main content
. 2018 Jan 31;9:57–68. doi: 10.1016/j.molmet.2018.01.011

Figure 1.

Figure 1

Efficient differentiation of XM001 iPSCs into pancreatic progenitors. (A) Schematic of iPSC-derived pancreatic progenitor differentiation protocol. (B) Immunostaining for FOXA2 and SOX17 on day 3. Scale bar indicates 50 μm. (C) Representative FACS plot of SOX17+ cells at DE stage. A differentiated sample stained with only the secondary antibody and XM001 iPSCs were used as negative controls. (D) FACS quantification of the percentage of SOX17+ cells at DE stage (n = 3). (E) Immunostaining for PDX1 on day 10. Scale bar indicates 50 μm. (F) Representative FACS plot of PDX1+ cells at the PP stage. A differentiated sample stained with only the secondary antibody and XM001 iPSCs were used as negative controls. (G) FACS quantification of the percentage of PDX1+ cells at PP stage (n = 3).